HMG-CoA reductase inhibitors have been associated with skeletal muscle myopathy, ranging from asymptomatic elevations of serum creatine kinase (CK) activity to rhabdomyolysis. In this study, we assessed the effects of addition of different concentrations of simvastatin and pravastatin on growth and differentiation of cultured primary rat skeletal muscle cells. Protein concentration, CK activity and percentage CK-MM, which is a parameter for maturation, were determined. Effects were generally stronger if inhibitors were added to both growth and differentiation medium rather than only to differentiation medium. Addition of 25 /xM pravastatin caused only a decrease of CK activity. Addition of 1 -5 ¿¿M simvastatin resulted in a decrease of protein concentration, CK activity and percentage CK-MM, whereas 25 /¿M simvastatin resulted in cell death. Addition of mevalonic acid or cholesterol could not prevent the effects of 1 /xM simvastatin. In addition, 1 ¿iM simvastatin did not influence the cholesterol and phospholipid content of the cells. Superfusion of cultured cells with simvastatin concentrations of 10 /¿M and higher caused a transient increase of the cytoplasmic calcium concentration followed by an apparent second rise and cell puncture. The results indicate that HMG-CoA reductase inhibitors may affect skeletal muscle cell regeneration in vivo by a direct toxic effect on growth and differentiation.
Introduction

Inhibitors of 3 -h y d r o x y -3 -m e t h y J g 1 u tar y 1 -C
A (HMG-CoA) reductase have gained an important place in the treatment of hypercholesterolaemia. They inhibit the conversion from HMG-CoA into mevalonate, the ratelimiting step in cholesterol synthesis, and thereby reduce . This leads to an the intracellular pool of enhanced synthesis of receptors for low density lipoprotein (LDL) cholesterol and increased clearance of these parti cles from the circulation [1] [2] [3] [4] . The current understanding hypolipidemic and an t'd r mechanism of tiatherosclerotic action of HMG-CoA reductase inhibitors been discussed [5] .
Concern has risen about skeletal muscle during treatment with these drugs, ranging from asymptomatic elevations of serum creatine kinase (CK) activity and myopathy to rhabdomyolysis [6] [7] [8] [9] [10] [11] [12] [13] [14] . Myopa thy (muscle tenderness and CK levels exceeding more than 10 times the upper limit of normal) has been found espe cially during combination therapy with gemfibrozil [6] [7] [8] [9] . Rhabdomyolysis has been observed in combinations with erythromycin, niacin or cyclosporin [10] [11] [12] [13] [14] . Cyclosporin of HMG-CoA reductase in hibitors due to inhibition of their biliary excretion [1 1], in animals, severe muscle damage can be induced by HMG-CoA reductase inhibitors [15] [16] [17] [18] especially when comwith cyclosporin [15] . The lipophilic HMG-CoA reductase inhibitor simvastatin seems to have more pro nounced effects than the hydrophilic compound pravastatin [1 7 ]. pravastatin on growth and differentiation of cultured rat skeletal muscle cells, and if present, whether these effects are related to inhibition of synthesis of mevalonate and/or cholesterol. D M E M /4 mM glutamine medium containing 0.4% Ultroser G and 10% rat brain extract.
Indicated concentrations of pravastatin, simvastatin, mevalonic acid or cholesterol were added at day 1 to growth medium and/or at confluency to differentiation medium.
Materials and methods
2.3. Biochemical assays 2.1. Materials Ultroser G was purchased from Gibco (Brussels, Bel gium). Simvastatin and pravastatin were obtained from Merck, Sharp and Dohme and Bristol Myers Squibb, re spectively. Mevalonic acid and Fura-2/AM were pur chased from Sigma Chemical Co. (St. Louis, MO). Brain extract was prepared from brains of 10-day-old Wistar rats. Homogenates (100 m g /m l Dulbecco's modified Eagle's medium (DMEM)) were centrifuged for 60 min at 100000 (0-4°C). The supernatant was stored at -70°C until use.
Rat muscle cell cultures
Protein content was assayed according to Lowry et al. [20] with bovine serum albumin as standard. CK activity was assayed as previously described [21] . For the determi nation of the percentage CK MM (CK-MM) as a measure of the maturation grade of muscle cells, this isoenzyme was separated from the other CK isoenzymes by anion exchange chromatography and analysed as reported [21] . Lipids were extracted according to Bligh and Dyer Total cholesterol was determined by an enzymatic method (CHOD-PAP, Sigma, St. Louis). Free and cholesterol were determined as described before [23] . Phospholipids were assayed on the basis of lipid-phosphorus content [24] and phospholipid composition by twodimensional TLC [25] . Satellite cells were isolated from quadriceps muscle of 10-day-old Wistar albino rats. The muscle (about 100 mg) was dissociated according to the dispersion technique of Yasin et al. [19] . Mononuclear cells (5 X 104) were plated in 35-mm plastic tissue culture dishes in DMEM medium containing 20% foetal calf serum, 2% chicken embryo extract, and 4 mM glutamine. Cells were cultured at 37°C in a humidified CO0 (5%) atmosphere. After one day, non-adhering cells and cell debris were discharged by washing twice with the same medium. Subsequently, cells were cultured for 5 -6 days to confluency in D M E M /4 mM glutamine containing 4% Ultroser G and 10% rat brain extract. Differentiation took place for 6 -7 days in
Ca + homeostasis assays
The free cytosolic Ca2+ concentration [Ca2 + ]¡ was determined in cultured cells using Fura-2 ratio measure ment [26]. Muscle cells were grown on glass coverslips (30 X 10 mm) in sera-containing proliferation and differen tiation media [27] . Myotubes were washed with physio logical salt solution (PSS, containing in mM: 125 NaCl, 10 N aliC O j, 1 NaH 2 P 0 4, 5 KC1, 2 M gS04, 1.8 CaCl2, 10 10 glucose, pH 7.4) and loaded with 5 /xM Fura-2/AM in PSS for 60 min at 37°C in the presence of 5% C 0 2 and 95% air. Excess of dye was removed by Table 1 Effects of pravastatin and simvastatin on cultured rut skeletal muscle cells 
Results
Optimal conditions for proliferation and differentiation of rat muscle cells were applied as previously described [27] . Relatively large variations are present in the protein content and the CK activity of different experiments due to culture variations and different amounts of contaminating fibroblasts. Therefore we calculated and compared their relative values in the presence of pravastatin, simvastatin and other additions. The percentage of CK-MM, a marker of muscle cell maturation, showed slight variability be tween the different experiments.
The effects of addition of different concentrations of simvastatin and pravastatin on protein content, CK activity and percentage CK-MM of cultured rat skeletal muscle are given in Table 1 . In all were were to medium, than only medium. Pravastatin had only limited effects, even when added in high concentrations ( creased significantly after addition of 1 and 5 ¡1M simvas tatin to both growth and differentiation medium. As shown in Table 2 , the effects of addition of 1 ¡xM simvastatin to growth and differentiation medium could not be reversed by concomitant addition of either meval onic acid or cholesterol. In Table 3 , the effects of addition of 1 fiM simvastatin to growth and differentiation medium on lipid content of rat muscle cells are given. No indica tions for a decreased cholesterol content or changes in the ratio free/esterified cholesterol were found. The content of total phospholipid was not decreased either, nor were significant differences observed in the phospholipid com position and the cholesterol/phospholipid ratio. (Table 4 ). In contrast to physiological stimulation with acetylcholine [26], this increase did not occur in the absence of extracel lular Ca24 and presence of 1 mM EGTA and is thus from extracellular origin. If cells were maintained in the pres ence of 10-50 uM simvastatin the [Ca2 1 L increased a second time and decreased subsequently, but the measure ment of Fura fluorescence showed a decrease at both wavelengths (340 and 380 nm), indicating the leakage of Fura through the cell membrane (Fig. 2) . The time interval between the two peaks of Ca2+ depended on the simvas tatin concentration. Similar results were obtained with cultured human skeletal muscle cells as with those from rat.
The presence of brain extract in the medium was not cause of the absence of counteracting effects of meval onate and cholesterol. of brain extract erowth and differentiation medium caused a decrease of protein concentration, CK activity and CK-MM percentage of control and simvastatin-treated cells. However, simvas tatin addition had a comparable effect as on cells cultured with brain extract, which could not be restored by addition
Discussion
The present study was performed to get insight into the effects of HMG-CoA reductase i during growth S. and proliferation of skeletal muscle compound simvastatin had substantial effects on protein , CK activity and percentage of CK-MM. In high concentration, simvastatin caused cell puncture and in culture cell detachment and death. In contrast, pravastatin had only a limited effect. Exposure of 8-day-old cultures of rat myotubes for 48 h to lovastatin, simvastatin or pravastatin also showed the lowest myotoxicity of the last, hydrophilic drug [28] . Pravastatin was also much inhibitory in various other types of human extrahepatic cells [29] [30] [31] [32] [29] [30] [31] [32] [33] [34] [35] . These effects could be prevented or restored by addition of mevalonate, but not by cholesterol. Mevalonate is not only a precursor for cholesterol, but also delivers isoprenoid groups for synthesis of farnesyl-and geranylmolecules are substrates for translational modification of proteins (as, e.g., Ras pro teins, nuclear lamins and G-proteins, and for synthesis of dolichol and ubiquinone, that have important regulatory functions in cell metabolism and growth [36] [37] [38] .
HMG-CoA reductase inhibitors as simvastatin, fluvastatin and lovastatin inhibit proliferation of arterial wall smooth muscle cells, glioma cells and mamma tumor cells
Lovastatin and nievastatin inhibited the fusion of L6 rat myoblasts and the concurrent increase of CK activity [39] . A cause could be the lack of dolichol phosphate oligo saccharide for glycoprotein synthesis [39] , The decreased isoprenylation of proteins and the decrease of coenzyme Q could be other mechanisms of interference with cell growth [38, 40] , In addition, shortage of cholesterol could affect cell membrane stability. However, in the present study, the additions of mevalonate and cholesterol were not able to prevent the effects o f simvastatin on the cultured skeletal s. Moreover, addition of simvastatin to the medium did not change the cholesterol and phospholipid content of the cells. Apparently, another mechanism, not to of mevalonate plays a role. Recently it has been suggested that disruption of early events in insulin signalling is a potential mecha nism for the 2nic activity of lovastatin . The concentration of lovastatin necess w >'\ssary to induce growth inhibition and apoptosis is a thousand-fold higher in glioma cells than in normal glial cells [42]. So a specific sensitiv ity of cells seems to be involved. Lack of products from HMG-CoA may partially be compensated in our cultured cells by the addition of brain extract to the medium, but also in its absence the same changes were observed.
Plasma cholesterol-lowering drugs as c lofi brate and 20,25-diazocholesterol have myotoxic effects as well, and induce myotonic discharges [43, 44] 
